Loading clinical trials...
Loading clinical trials...
Multiple Dose, Double-Blind, Double-Dummy, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness From Exercise
Conditions
Interventions
Diractin
Diractin
Locations
1
Germany
X-pert Med GmbH
Jena, Thuringia, Germany
Start Date
October 1, 2007
Primary Completion Date
February 1, 2008
Completion Date
November 1, 2008
Last Updated
March 20, 2009
NCT06225388
NCT06810271
NCT07438431
NCT05326893
NCT06535906
NCT06612502
Lead Sponsor
IDEA AG
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions